1 Introduction to Research & Analysis Reports
1.1 Pediatric ADHD Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatric ADHD Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pediatric ADHD Drugs Overall Market Size
2.1 Global Pediatric ADHD Drugs Market Size: 2022 VS 2029
2.2 Global Pediatric ADHD Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pediatric ADHD Drugs Players in Global Market
3.2 Top Global Pediatric ADHD Drugs Companies Ranked by Revenue
3.3 Global Pediatric ADHD Drugs Revenue by Companies
3.4 Top 3 and Top 5 Pediatric ADHD Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pediatric ADHD Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pediatric ADHD Drugs Players in Global Market
3.6.1 List of Global Tier 1 Pediatric ADHD Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Pediatric ADHD Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Pediatric ADHD Drugs Market Size Markets, 2022 & 2029
4.1.2 Tablets
4.1.3 Oral Liquid
4.1.4 Other
4.2 By Type – Global Pediatric ADHD Drugs Revenue & Forecasts
4.2.1 By Type – Global Pediatric ADHD Drugs Revenue, 2018-2023
4.2.2 By Type – Global Pediatric ADHD Drugs Revenue, 2024-2029
4.2.3 By Type – Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pediatric ADHD Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application – Global Pediatric ADHD Drugs Revenue & Forecasts
5.2.1 By Application – Global Pediatric ADHD Drugs Revenue, 2018-2023
5.2.2 By Application – Global Pediatric ADHD Drugs Revenue, 2024-2029
5.2.3 By Application – Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Pediatric ADHD Drugs Market Size, 2022 & 2029
6.2 By Region – Global Pediatric ADHD Drugs Revenue & Forecasts
6.2.1 By Region – Global Pediatric ADHD Drugs Revenue, 2018-2023
6.2.2 By Region – Global Pediatric ADHD Drugs Revenue, 2024-2029
6.2.3 By Region – Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Pediatric ADHD Drugs Revenue, 2018-2029
6.3.2 US Pediatric ADHD Drugs Market Size, 2018-2029
6.3.3 Canada Pediatric ADHD Drugs Market Size, 2018-2029
6.3.4 Mexico Pediatric ADHD Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Pediatric ADHD Drugs Revenue, 2018-2029
6.4.2 Germany Pediatric ADHD Drugs Market Size, 2018-2029
6.4.3 France Pediatric ADHD Drugs Market Size, 2018-2029
6.4.4 U.K. Pediatric ADHD Drugs Market Size, 2018-2029
6.4.5 Italy Pediatric ADHD Drugs Market Size, 2018-2029
6.4.6 Russia Pediatric ADHD Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Pediatric ADHD Drugs Market Size, 2018-2029
6.4.8 Benelux Pediatric ADHD Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Pediatric ADHD Drugs Revenue, 2018-2029
6.5.2 China Pediatric ADHD Drugs Market Size, 2018-2029
6.5.3 Japan Pediatric ADHD Drugs Market Size, 2018-2029
6.5.4 South Korea Pediatric ADHD Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Pediatric ADHD Drugs Market Size, 2018-2029
6.5.6 India Pediatric ADHD Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Pediatric ADHD Drugs Revenue, 2018-2029
6.6.2 Brazil Pediatric ADHD Drugs Market Size, 2018-2029
6.6.3 Argentina Pediatric ADHD Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Pediatric ADHD Drugs Revenue, 2018-2029
6.7.2 Turkey Pediatric ADHD Drugs Market Size, 2018-2029
6.7.3 Israel Pediatric ADHD Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Pediatric ADHD Drugs Market Size, 2018-2029
6.7.5 UAE Pediatric ADHD Drugs Market Size, 2018-2029
7 Pediatric ADHD Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pediatric ADHD Drugs Major Product Offerings
7.1.4 Pfizer Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Pediatric ADHD Drugs Major Product Offerings
7.2.4 Johnson & Johnson Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Company Summary
7.3.2 Eli Lilly and Company Business Overview
7.3.3 Eli Lilly and Company Pediatric ADHD Drugs Major Product Offerings
7.3.4 Eli Lilly and Company Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly and Company Key News & Latest Developments
7.4 Tris Pharma
7.4.1 Tris Pharma Company Summary
7.4.2 Tris Pharma Business Overview
7.4.3 Tris Pharma Pediatric ADHD Drugs Major Product Offerings
7.4.4 Tris Pharma Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.4.5 Tris Pharma Key News & Latest Developments
7.5 Noven Pharmaceuticals
7.5.1 Noven Pharmaceuticals Company Summary
7.5.2 Noven Pharmaceuticals Business Overview
7.5.3 Noven Pharmaceuticals Pediatric ADHD Drugs Major Product Offerings
7.5.4 Noven Pharmaceuticals Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.5.5 Noven Pharmaceuticals Key News & Latest Developments
7.6 Alcobra Pharmaceuticals
7.6.1 Alcobra Pharmaceuticals Company Summary
7.6.2 Alcobra Pharmaceuticals Business Overview
7.6.3 Alcobra Pharmaceuticals Pediatric ADHD Drugs Major Product Offerings
7.6.4 Alcobra Pharmaceuticals Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.6.5 Alcobra Pharmaceuticals Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Pediatric ADHD Drugs Major Product Offerings
7.7.4 Novartis Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Pediatric ADHD Drugs Major Product Offerings
7.8.4 GlaxoSmithKline Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Purdue Pharma
7.9.1 Purdue Pharma Company Summary
7.9.2 Purdue Pharma Business Overview
7.9.3 Purdue Pharma Pediatric ADHD Drugs Major Product Offerings
7.9.4 Purdue Pharma Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.9.5 Purdue Pharma Key News & Latest Developments
7.10 Takeda Pharmaceutical
7.10.1 Takeda Pharmaceutical Company Summary
7.10.2 Takeda Pharmaceutical Business Overview
7.10.3 Takeda Pharmaceutical Pediatric ADHD Drugs Major Product Offerings
7.10.4 Takeda Pharmaceutical Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.10.5 Takeda Pharmaceutical Key News & Latest Developments
7.11 Curemark
7.11.1 Curemark Company Summary
7.11.2 Curemark Business Overview
7.11.3 Curemark Pediatric ADHD Drugs Major Product Offerings
7.11.4 Curemark Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.11.5 Curemark Key News & Latest Developments
7.12 Supernus Pharmaceuticals
7.12.1 Supernus Pharmaceuticals Company Summary
7.12.2 Supernus Pharmaceuticals Business Overview
7.12.3 Supernus Pharmaceuticals Pediatric ADHD Drugs Major Product Offerings
7.12.4 Supernus Pharmaceuticals Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.12.5 Supernus Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
世界の小児用ADHD治療薬市場予測2023-2029：錠剤、経口液、その他 |
| 【英語タイトル】Pediatric ADHD Drugs Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5879 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：65 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の小児用ADHD治療薬市場規模と予測を収録しています。・世界の小児用ADHD治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界の小児用ADHD治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の小児用ADHD治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「錠剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 小児用ADHD治療薬のグローバル主要企業は、Pfizer、 Johnson & Johnson、 Eli Lilly and Company、 Tris Pharma、 Noven Pharmaceuticals、 Alcobra Pharmaceuticals、 Novartis、 GlaxoSmithKline、 Purdue Pharma、 Takeda Pharmaceutical、 Curemark、 Supernus Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、小児用ADHD治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の小児用ADHD治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の小児用ADHD治療薬市場：タイプ別市場シェア、2022年 ・錠剤、経口液、その他 世界の小児用ADHD治療薬市場：用途別、2018年-2023年、2024年-2029年 世界の小児用ADHD治療薬市場：用途別市場シェア、2022年 ・病院、小売薬局、その他 世界の小児用ADHD治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の小児用ADHD治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における小児用ADHD治療薬のグローバル売上、2018年-2023年 ・主要企業における小児用ADHD治療薬のグローバル売上シェア、2022年 ・主要企業における小児用ADHD治療薬のグローバル販売量、2018年-2023年 ・主要企業における小児用ADHD治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer、 Johnson & Johnson、 Eli Lilly and Company、 Tris Pharma、 Noven Pharmaceuticals、 Alcobra Pharmaceuticals、 Novartis、 GlaxoSmithKline、 Purdue Pharma、 Takeda Pharmaceutical、 Curemark、 Supernus Pharmaceuticals ************************************************************* ・調査・分析レポートの概要 小児用ADHD治療薬市場の定義 市場セグメント 世界の小児用ADHD治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の小児用ADHD治療薬市場規模 世界の小児用ADHD治療薬市場規模：2022年 VS 2029年 世界の小児用ADHD治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの小児用ADHD治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の小児用ADHD治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：錠剤、経口液、その他 小児用ADHD治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、小売薬局、その他 小児用ADHD治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別小児用ADHD治療薬市場規模 2022年と2029年 地域別小児用ADHD治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer、 Johnson & Johnson、 Eli Lilly and Company、 Tris Pharma、 Noven Pharmaceuticals、 Alcobra Pharmaceuticals、 Novartis、 GlaxoSmithKline、 Purdue Pharma、 Takeda Pharmaceutical、 Curemark、 Supernus Pharmaceuticals ... |
This report aims to provide a comprehensive presentation of the global market for Pediatric ADHD Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric ADHD Drugs. This report contains market size and forecasts of Pediatric ADHD Drugs in global, including the following market information:
Global Pediatric ADHD Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pediatric ADHD Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pediatric ADHD Drugs include Pfizer, Johnson & Johnson, Eli Lilly and Company, Tris Pharma, Noven Pharmaceuticals, Alcobra Pharmaceuticals, Novartis, GlaxoSmithKline and Purdue Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pediatric ADHD Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric ADHD Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pediatric ADHD Drugs Market Segment Percentages, by Type, 2022 (%)
Tablets
Oral Liquid
Other
Global Pediatric ADHD Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pediatric ADHD Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Pediatric ADHD Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pediatric ADHD Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatric ADHD Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pediatric ADHD Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Eli Lilly and Company
Tris Pharma
Noven Pharmaceuticals
Alcobra Pharmaceuticals
Novartis
GlaxoSmithKline
Purdue Pharma
Takeda Pharmaceutical
Curemark
Supernus Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pediatric ADHD Drugs, market overview.
Chapter 2: Global Pediatric ADHD Drugs market size in revenue.
Chapter 3: Detailed analysis of Pediatric ADHD Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pediatric ADHD Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の小児用ADHD治療薬市場予測2023-2029：錠剤、経口液、その他] (コード：MMG23JU5879)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の小児用ADHD治療薬市場予測2023-2029：錠剤、経口液、その他]についてメールでお問い合わせ |
